NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today ...
Third Quarter Highlighted by Initiation of Phase 3 Study of PF614, Underscoring Progress Toward Market Readiness and Commitment to Novel Opioid Solutions ~ ~ Further Program Advancement Supported by ...
Launched in the summer of 1982, Diet Coke was marketed as a healthier alternative to regular soda - without the sugar or ...
In season two, the big dance number illustrates the "special relationship" between the main character Wednesday's roommate ...
Heretic, debater, wife-snatcher, subject of a posthumous cult: Pico della Mirandola certainly had a wild career. In this ...
Bristol Myers Squibb in collaboration with Johnson & Johnson today announced the decision to stop the Phase 3 Librexia ACS trial evaluating the efficacy and safety of milvexian when added to the ...
News-Medical.Net on MSN
MD Anderson launches historic $2.5 billion campaign to end cancer
The University of Texas MD Anderson Cancer Center today launches its historic $2.5 billion comprehensive philanthropic campaign, Only Possible Here, The Campaign to End Cancer.
Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced an update to the prescribing information for ELEVIDYS (delandistrogene moxeparvovec-rokl), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback